IPOPI, the International Patient Organisation for Primary Immunodeficiencies, is the Association of national patient organisations dedicated to improving awareness, access to early diagnosis and optimal treatments for primary immunodeficiency (PID) patients worldwide

Established in 1992, IPOPI works as the global advocate for the PID patient community in cooperation with its National Member Organisations (NMOs) and key PID stakeholders.

  • facebook join us
  • Follow us on twitter
  • YouTube watch us
Donate
  • Visit the new IPOPI TV
  • IPIC2015, Budapest, Hungary, 700 participants
  • Dsai, Germany, central and regional leaders
  • PID patient's meeting in Bangkok
Visit the new
IPOPI TV

News

Jun 15, 2016
GlaxoSmithKline (GSK), Fondazione Telethon and Ospedale San Raffaele (OSR) recently announced that the European Commission approved Strimvelis, the first ex-vivo stem cell gene therapy for ADA-SCID
Jun 3, 2016
Shire today completed its previously announced combination with Baxalta.

Publications

Aug 29, 2016
IPOPI is pleased to announce the publication of the ‘PID Principles of Care Implementation Package’, a new key document designed specifically for our National Member Organisations (NMOs)
Apr 29, 2016
IPOPI is glad to release a new series of patient information leaflets during this World Primary Immunodeficiencies Week!

IPIC 2017

IPOPI Global Immunoglobulin list

Website Sponsors
sponsor

World PI Week

Biennial Meeting 2016